China, Aug. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, multicenter, randomized controlled clinical trial to evaluate the safety and efficacy of the fully absorbable radiopaque integrated patent foramen ovale occluder and the cardiac occluder delivery system for patent foramen ovale closure.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129736

Registration Time: 2026/08/10

Type: Interventional study

Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337419

Published by HT Digital Content Ser...